atropine has been researched along with tretinoin in 11 studies
Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (tretinoin) | Trials (tretinoin) | Recent Studies (post-2010) (tretinoin) |
---|---|---|---|---|---|
26,711 | 1,259 | 1,697 | 23,654 | 1,083 | 6,085 |
Protein | Taxonomy | atropine (IC50) | tretinoin (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 10 | |
Amyloid-beta precursor protein | Homo sapiens (human) | 0.18 | |
Adenosine receptor A3 | Homo sapiens (human) | 5.275 | |
Retinoic acid receptor alpha | Homo sapiens (human) | 2.2542 | |
60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 5.3 | |
Retinoic acid receptor beta | Homo sapiens (human) | 0.7537 | |
Retinoic acid receptor alpha | Mus musculus (house mouse) | 0.0057 | |
Retinoic acid receptor gamma | Homo sapiens (human) | 0.0064 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 5.275 | |
Retinoic acid receptor gamma | Mus musculus (house mouse) | 0.004 | |
Retinoic acid receptor beta | Mus musculus (house mouse) | 0.005 | |
Mitogen-activated protein kinase 1 | Homo sapiens (human) | 0.576 | |
Nuclear receptor ROR-alpha | Homo sapiens (human) | 0.1995 | |
Alpha-synuclein | Homo sapiens (human) | 3 | |
Cellular retinoic acid-binding protein 1 | Gallus gallus (chicken) | 0.5233 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.358 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 5.275 | |
Retinoic acid receptor RXR-gamma | Homo sapiens (human) | 0.35 | |
Nuclear receptor ROR-gamma | Homo sapiens (human) | 0.1995 | |
10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 5.3 | |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | 0.82 | |
60 kDa chaperonin | Escherichia coli | 6.7 | |
10 kDa chaperonin | Escherichia coli | 6.7 | |
Nuclear receptor ROR-beta | Homo sapiens (human) | 0.1259 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (27.27) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Habs, M; Schmähl, D | 1 |
Adem, A; Mattsson, ME; Nordberg, A; Påhlman, S | 1 |
Boutwell, RK; Conrad, EA; Kishore, GS; Perchellet, JP | 1 |
Borroni, B; Cattabeni, F; Colciaghi, F; Di Luca, M; Gardoni, F; Marcello, E; Padovani, A; Zimmermann, M | 1 |
Kataoka, H; Madhyastha, H; Madhyastha, R; Maruyama, M; Nakajima, Y; Nurrahmah, QI; Purbasari, B; Watanabe, N | 1 |
1 review(s) available for atropine and tretinoin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
10 other study(ies) available for atropine and tretinoin
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Life-span investigations for carcinogenicity of some immune-stimulating, immunodepressive and neurotropic substances in Sprague-Dawley-rats.
Topics: Animals; Antilymphocyte Serum; Atropine; BCG Vaccine; Carcinogens; Female; Freund's Adjuvant; Ganglionic Stimulants; Immunosuppressive Agents; Male; Neoplasms, Experimental; Phenobarbital; Rats; Serum Albumin; Tretinoin | 1976 |
Muscarinic receptors in human SH-SY5Y neuroblastoma cell line: regulation by phorbol ester and retinoic acid-induced differentiation.
Topics: Acetylcholinesterase; Atropine; Binding, Competitive; Cell Differentiation; Cell Line; Choline O-Acetyltransferase; Humans; Neuroblastoma; Pirenzepine; Quinuclidinyl Benzilate; Receptors, Muscarinic; Tetradecanoylphorbol Acetate; Tretinoin | 1987 |
Effects of cell surface receptor-altering agents on the binding and biological activity of 12-O-tetradecanoylphorbol-13-acetate in isolated epidermal cells.
Topics: alpha-L-Fucosidase; Animals; Atropine; Binding Sites; Binding, Competitive; Carboxy-Lyases; Cell Membrane; Cholera Toxin; G(M1) Ganglioside; Galactose Oxidase; Kinetics; Mice; Neuraminidase; Ornithine Decarboxylase; Phentolamine; Phorbols; Phospholipases; Propranolol; Skin; Tetradecanoylphorbol Acetate; Tretinoin | 1982 |
Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines.
Topics: Acetylcholinesterase; ADAM Proteins; ADAM10 Protein; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Atropine; Blotting, Western; Brefeldin A; Bungarotoxins; Carbachol; Cell Differentiation; Cell Fractionation; Cell Line, Tumor; Cholinergic Agonists; Cholinesterase Inhibitors; Donepezil; Drug Interactions; Embryo, Mammalian; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Humans; Indans; Membrane Proteins; Metalloendopeptidases; Microscopy, Confocal; Muscarinic Antagonists; Neuroblastoma; Physostigmine; Piperidines; Protein Synthesis Inhibitors; Protein Transport; Tretinoin | 2004 |
Retinoic acid attenuates nuclear factor kappaB mediated induction of NLRP3 inflammasome.
Topics: Acetylcholine; Animals; Atropine; Carbachol; Cholinergic Agonists; Humans; Inflammasomes; Macrophages; Mice; Muscarinic Antagonists; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Receptors, Muscarinic; Signal Transduction; Tretinoin | 2022 |